Latanoprost Yonsung

Latanoprost, the active ingredient in Latanoprost Yonsung, is a prostaglandin analog presented as an eye‑drop solution for ocular use. It lowers intra‑ocular pressure and is prescribed for open‑angle glaucoma and ocular hypertension in adult patients, providing long‑term management to help prevent optic nerve damage.

GNH USA supplies Latanoprost Yonsung as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics across global markets while adhering to stringent quality and regulatory standards. The company ensures timely delivery and supports regulatory documentation for importation.

Latanoprost is a prostaglandin analog used to reduce intra‑ocular pressure in glaucoma and ocular hypertension. - Open‑angle glaucoma: lowers intra‑ocular pressure to help prevent progression of optic nerve damage. - Ocular hypertension: reduces elevated eye pressure in patients at risk of developing glaucoma. - Elevated intra‑ocular pressure: provides sustained pressure reduction for long‑term management.

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and transient. Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eye irritation: transient burning or stinging sensation. - Increased eyelash growth: longer, thicker lashes. - Darkening of iris: gradual brownish pigmentation. Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis: inflammation of the uveal tract.

Before prescribing Latanoprost, clinicians should consider several safety precautions. - Contraindication: avoid use in patients with known hypersensitivity to latanoprost or any component of the formulation. - Caution: monitor intra‑ocular pressure after initiation, as response may vary. - Interaction: avoid concurrent use with other prostaglandin analogs without medical supervision. - Pregnancy: safety not established; use only if potential benefit justifies potential risk. - Breastfeeding: unknown excretion in milk; weigh benefits against risks before prescribing. - Store at room temperature: keep the bottle in the original packaging, protect from light and freeze, and discard after the indicated period after opening.

Latanoprost can interact with other ocular or systemic agents, affecting its efficacy or safety. Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory eye drops: may reduce prostaglandin effect and increase intra‑ocular pressure. - Systemic beta‑blockers: combined pressure‑lowering may cause excessive reduction, requiring monitoring. Moderate Interactions (Monitor Closely): - Carbonic anhydrase inhibitors: additive IOP‑lowering effect may increase risk of hypotony. - Anticholinergic eye drops: may affect tear film and comfort. - Herbal supplements containing prostaglandins: potential additive ocular effects.